Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analysts raised targets across financials and healthcare on Tuesday, with Goldman Sachs seeing the sharpest jump. The average consensus target for GS rose to $1,085 from $1,037. That is a near-$50 increase. Goldman stock carries a market cap of $350 billion. Short interest sits at just 2.1% of free float.
Eli Lilly also drew fresh upgrades. Its average target climbed to $1,270. The pharma giant crossed $1 trillion in market cap. Analysts remain overwhelmingly bullish — 22 buys, five holds, and just one sell in the consensus.
UnitedHealth Group targets edged up to $438 from $436. The insurer has faced heavy scrutiny in 2026. The target increase signals some renewed confidence. Consensus counts 22 buys and only one sell.
Two names bucked the trend. Microsoft saw a minor target trim, down to $559 from $560. also slipped, with targets cut to $284 from $285.
PNC Financial rounded out the financials story. Its target rose to $270. Progressive was the only insurer to see a target dip, down to $234.
Overall, the session leaned bullish. Financial and healthcare names drove most of the upward revisions.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
